Fifth Third Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Fifth Third Wealth Advisors LLC
- $1.63 Trillion
- Q3 2024
A detailed history of Fifth Third Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 4,330 shares of HALO stock, worth $212,170. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,330
Previous 4,296
0.79%
Holding current value
$212,170
Previous $225 Million
10.18%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$863 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$632 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$325 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$199 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$167 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.83B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...